Calvaruso, Vincenza <br/><br/>
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program.  [electronic resource] 

 -  Scientific reports  01 2019 
 - 585 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/s41598-018-36734-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antiviral Agents--adverse effects<br/>Carbamates<br/>Drug Therapy, Combination--methods<br/>Drug-Related Side Effects and Adverse Reactions<br/>Female<br/>Hepatitis C, Chronic--complications<br/>Humans<br/>Imidazoles--adverse effects<br/>Isoquinolines--therapeutic use<br/>Italy<br/>Liver Cirrhosis--drug therapy<br/>Liver Function Tests<br/>Male<br/>Middle Aged<br/>Pyrrolidines<br/>Ribavirin--therapeutic use<br/>Sofosbuvir--therapeutic use<br/>Sulfonamides--therapeutic use<br/>Sustained Virologic Response<br/>Treatment Outcome<br/>Valine--analogs & derivatives